UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx Study

Cancers, 2023-02, Vol.15 (5), p.1529

2023

Link zum Volltext

Verfügbarkeit prüfen

Gene expression profiling involved in response to neoadjuvant therapy in breast cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e12618-e12618

2020

Link zum Volltext

Verfügbarkeit prüfen

Pathologic complete response (pCR) to neoadjuvant treatment (NAT) with carboplatin, nab-paclitaxel and anthracycline in early and locally advanced triple-negative breast cancer (TNBC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e12608-e12608

2023

Link zum Volltext

Verfügbarkeit prüfen

Lurbinectedin (LUR) in combination with Irinotecan (IRI) in patients (pts) with advanced endometrial carcinoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5586-5586

2021

Link zum Volltext

Verfügbarkeit prüfen

Derazantinib (DZB) in combination with atezolizumab (AZB) in patients with solid tumors: Results from the dose-finding phase Ib substudy of FIDES-02

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.437-437

2021

Link zum Volltext

Verfügbarkeit prüfen

Lurbinectedin (LUR) in combination with Irinotecan (IRI) in patients (pts) with advanced solid tumors: Updated results from a phase Ib-II trial

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3514-3514

2020

Link zum Volltext

Verfügbarkeit prüfen

P3.02c-034 A Single Institution Experience with Immunotherapy as an Effective Therapy Approach of Advance Non-Small Cell Lung Cancer (NSCLC): Topic: IT

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1293-S1294

2017

Link zum Volltext

Verfügbarkeit prüfen

P3.02c-034 A Single Institution Experience with Immunotherapy as an Effective Therapy Approach of Advance Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1293-S1294

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT129: A multicohort, open-label, phase 2 basket study of the coformulation of vibostolimab with pembrolizumab, with or without other anticancer therapies, in select solid tumors

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT129-CT129

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

Breast cancer research and treatment, 2024-04, Vol.204 (2), p.237-248

2024

Link zum Volltext

Verfügbarkeit prüfen

Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients

BMC palliative care, 2021-01, Vol.20 (1), p.1-8, Article 1

2021

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Prognostic and Therapeutic Factors in Male Breast Cancer: An Observational Study of a Southwest Spanish Single Center

Archives of breast cancer, 2020-11, p.155-163

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS11-05: Updated data from SERENA-1: A Phase 1 dose escalation and expansion study of the next generation oral SERD AZD9833 as a monotherapy and in combination with palbociclib, in women with ER-positive, HER2-negative advanced breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS11-05-PS11-05

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting immune checkpoints in melanoma: an update

Melanoma management, 2015-11, Vol.2 (4), p.339-352

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis

European journal of cancer (1990), 2021-07, Vol.152, p.68-77

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-18-29: Neopersur: Neoadjuvant pertuzumab in a real world data population in the south of Spain

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P1-P1-18-29

2020

Link zum Volltext

Verfügbarkeit prüfen

Continuous Sliding-Mode Control Strategies for Quadrotor Robust Tracking: Real-Time Application

IEEE transactions on industrial electronics (1982), 2019-02, Vol.66 (2), p.1264-1272

2019

Link zum Volltext
IEEE_Xplore

Assessment of the Wolf method using the Stillinger–Lovett sum rules: From strong electrolytes to weakly charged colloidal dispersions

The Journal of chemical physics, 2020-12, Vol.153 (23), p.234901-234901

2020

Link zum Volltext

Verfügbarkeit prüfen

Brownian dynamics simulations and Ornstein-Zernike equation for charged fluids using the Wolf potential

Journal of molecular liquids, 2023-11, Vol.390, p.123106, Article 123106

2023

Link zum Volltext

Verfügbarkeit prüfen

2-Benzyl-7-(4-chlorophenyl)-3-morpholino-6-((1-phenyl-1H-1,2,3-triazol-4-yl)methyl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one

MolBank, 2023-09, Vol.2023 (3), p.M1693

2023

Link zum Volltext

Verfügbarkeit prüfen

Chitosan induces tomato basal resistance against Phytophthora nicotianae and inhibits pathogen development

Canadian journal of plant pathology, 2022-05, Vol.44 (3), p.400-414

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of adenylyl cyclase 8 prevents the upregulation of Orai1 channel, which improves cardiac function after myocardial infarction

Molecular therapy, 2024-03, Vol.32 (3), p.646-662

2024

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers involved in the neoadjuvant therapy response in triple-negative and Her2+ subtypes breast cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e12098-e12098

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(82)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx Study

Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study

Gene expression profiling involved in response to neoadjuvant therapy in breast cancer

Pathologic complete response (pCR) to neoadjuvant treatment (NAT) with carboplatin, nab-paclitaxel and anthracycline in early and locally advanced triple-negative breast cancer (TNBC)

Lurbinectedin (LUR) in combination with Irinotecan (IRI) in patients (pts) with advanced endometrial carcinoma

Derazantinib (DZB) in combination with atezolizumab (AZB) in patients with solid tumors: Results from the dose-finding phase Ib substudy of FIDES-02

Lurbinectedin (LUR) in combination with Irinotecan (IRI) in patients (pts) with advanced solid tumors: Updated results from a phase Ib-II trial

P3.02c-034 A Single Institution Experience with Immunotherapy as an Effective Therapy Approach of Advance Non-Small Cell Lung Cancer (NSCLC): Topic: IT

P3.02c-034 A Single Institution Experience with Immunotherapy as an Effective Therapy Approach of Advance Non-Small Cell Lung Cancer (NSCLC)

Abstract CT129: A multicohort, open-label, phase 2 basket study of the coformulation of vibostolimab with pembrolizumab, with or without other anticancer therapies, in select solid tumors

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations

Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients

Assessment of Prognostic and Therapeutic Factors in Male Breast Cancer: An Observational Study of a Southwest Spanish Single Center

Abstract PS11-05: Updated data from SERENA-1: A Phase 1 dose escalation and expansion study of the next generation oral SERD AZD9833 as a monotherapy and in combination with palbociclib, in women with ER-positive, HER2-negative advanced breast cancer

Targeting immune checkpoints in melanoma: an update

Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis

Abstract P1-18-29: Neopersur: Neoadjuvant pertuzumab in a real world data population in the south of Spain

Continuous Sliding-Mode Control Strategies for Quadrotor Robust Tracking: Real-Time Application

Assessment of the Wolf method using the Stillinger–Lovett sum rules: From strong electrolytes to weakly charged colloidal dispersions

Brownian dynamics simulations and Ornstein-Zernike equation for charged fluids using the Wolf potential

2-Benzyl-7-(4-chlorophenyl)-3-morpholino-6-((1-phenyl-1H-1,2,3-triazol-4-yl)methyl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one

Chitosan induces tomato basal resistance against Phytophthora nicotianae and inhibits pathogen development

Inhibition of adenylyl cyclase 8 prevents the upregulation of Orai1 channel, which improves cardiac function after myocardial infarction

Biomarkers involved in the neoadjuvant therapy response in triple-negative and Her2+ subtypes breast cancer

Suchergebnisse filtern